<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">perinatology</journal-id><journal-title-group><journal-title xml:lang="ru">Российский вестник перинатологии и педиатрии</journal-title><trans-title-group xml:lang="en"><trans-title>Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1027-4065</issn><issn pub-type="epub">2500-2228</issn><publisher><publisher-name>Ltd. “The National Academy of Pediatric Science and Innovation”</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21508/1027-4065-2021-66-4-25-31</article-id><article-id custom-type="elpub" pub-id-type="custom">perinatology-1440</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРЫ ЛИТЕРАТУРЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>LITERATURE REVIEWS</subject></subj-group></article-categories><title-group><article-title>Роль цитокинов в прогрессировании хронической болезни почек у детей</article-title><trans-title-group xml:lang="en"><trans-title>Cytokines and progressive chronic kidney disease in children</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5722-8490</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Макарова</surname><given-names>Т. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Makarova</surname><given-names>T. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Макарова Тамара Петровна – д.м.н., проф.кафедры госпитальной педиатрии</p><p>420012 Казань, ул. Бутлерова, д. 49</p></bio><bio xml:lang="en"><p>Kazan</p></bio><email xlink:type="simple">makarova-kgmu@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7533-3489</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ишбулдина</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Ishbuldina</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ишбулдина Анастасия Владимировна – к.м.н., асс. кафедры госпитальной педиатрии</p><p>420012 Казань, ул. Бутлерова, д. 49</p></bio><bio xml:lang="en"><p>Kazan</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО «Казанский государственный медицинский университет» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Kazan State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>27</day><month>09</month><year>2021</year></pub-date><volume>66</volume><issue>4</issue><fpage>25</fpage><lpage>31</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Ltd. “The National Academy of Pediatric Science and Innovation”, 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Ltd. “The National Academy of Pediatric Science and Innovation”</copyright-holder><copyright-holder xml:lang="en">Ltd. “The National Academy of Pediatric Science and Innovation”</copyright-holder><license xlink:href="https://www.ped-perinatology.ru/jour/about/submissions#copyrightNotice" xlink:type="simple"><license-p>https://www.ped-perinatology.ru/jour/about/submissions#copyrightNotice</license-p></license></permissions><self-uri xlink:href="https://www.ped-perinatology.ru/jour/article/view/1440">https://www.ped-perinatology.ru/jour/article/view/1440</self-uri><abstract><p>Проблема хронизации заболеваний почек остается одной из актуальных в нефрологии. Накоплены данные о многогранности механизмов участия цитокинов в развитии и прогнозировании патологических состояний. В выполненных в последние годы исследованиях особое внимание уделяется изучению механизмов местного воспаления с исследованием уровня интерлейкинов в моче. Цитокины осуществляют взаимосвязь между неспецифическими защитными реакциями и специфическим иммунитетом. Синтезируясь в очаге воспаления, цитокины воздействуют практически на все клетки, участвующие в воспалении. В случае несостоятельности местных защитных реакций цитокины попадают в циркуляцию и их действие проявляется на системном уровне, что приводит к развитию острофазового ответа в организме. В обзоре представлены данные о цитокиновом статусе при хронической болезни почек у детей и его роли в прогрессировании заболевания. Подчеркнута научная и практическая значимость исследований цитокинового статуса при хронических заболеваниях почек.</p></abstract><trans-abstract xml:lang="en"><p>The problem of chronickidney disease is one of the urgent problems in nephrology. There is data on the multifaceted participation of cytokines in the development and prognosis of pathological conditions. The recent studies are focusedon the mechanismsoflocal inflammation with the analysis of interleukins level in the urine. Cytokines are mediators between nonspecific defense reactions and specificimmunity. Being synthesized in the focus of inflammation, cytokines influence almost all cells involvedin inflammation. In case of local defense failure, cytokines enterthe circulation and act at the systemic level, developing an acutephaseresponse in the body. The review presents data on the cytokine status in chronic kidney disease in children and its rolein the progression oft he disease. The authors emphasize the scientific and practical significance of studies of the cytokine status in chronic kidney diseases.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>дети</kwd><kwd>интерлейкины</kwd><kwd>цитокины</kwd><kwd>хроническая болезнь почек</kwd><kwd>пиелонефрит</kwd><kwd>гломерулонефрит</kwd></kwd-group><kwd-group xml:lang="en"><kwd>children</kwd><kwd>interleukins</kwd><kwd>cytokines</kwd><kwd>chronic kidney disease</kwd><kwd>pyelonephritis</kwd><kwd>glomerulonephritis</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Hogg R.J., Furth S., LemeleyK.V., Portman R., Schwartz G.J, Coresh J. et al. National Kidney Foundation’s Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification and stratis-faction. Pediatrics 2003; 111(6): 1416–1421. DOI: 10.1542/peds.111.6.1416</mixed-citation><mixed-citation xml:lang="en">Hogg R.J., Furth S., LemeleyK.V., Portman R., Schwartz G.J, Coresh J. et al. National Kidney Foundation’s Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification and stratis-faction. Pediatrics 2003; 111(6): 1416–1421. DOI: 10.1542/peds.111.6.1416</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Ifuku M., Miyake K., Watanebe M., Ito K., Abe Y., SasatomiY. et al. Various roles of the cytokine mRNA expression in different forms of glomerulonephritis. Amer J Nephrol 2013; 38(2): 115–123. DOI: 10.1159/000353102</mixed-citation><mixed-citation xml:lang="en">Ifuku M., Miyake K., Watanebe M., Ito K., Abe Y., SasatomiY. et al. Various roles of the cytokine mRNA expression in different forms of glomerulonephritis. Amer J Nephrol 2013; 38(2): 115–123. DOI: 10.1159/000353102</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Suárez-Fueyo A., Bradley S.J., Klatzmann D., Tsokos G.C. T-cells and autoimmune kidney disease. Nat Rev Nephrol 2017; 13: 329–343. DOI: 10.1038/nrneph.2017.34</mixed-citation><mixed-citation xml:lang="en">Suárez-Fueyo A., Bradley S.J., Klatzmann D., Tsokos G.C. T-cells and autoimmune kidney disease. Nat Rev Nephrol 2017; 13: 329–343. DOI: 10.1038/nrneph.2017.34</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Орадова А.Ш., УстеноваГ.О., Стабаева Г.С. Методы исследования цитокинов (обзорная статья). Medicine 2014; 10: 84–87.</mixed-citation><mixed-citation xml:lang="en">Oradova A.Sh., Ustenova G.O., Stabaeva G.S. Methods of cytokine research (review article). Medicine 2014; 10: 84–87. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Su H., Lei C.T., Zhang C. Interleukin-6 Signaling Pathway and Its Role in Kidney Disease: An Update. Front Immunol 2017; 8: 405. DOI: 10.3389/fimmu.2017.00405</mixed-citation><mixed-citation xml:lang="en">Su H., Lei C.T., Zhang C. Interleukin-6 Signaling Pathway and Its Role in Kidney Disease: An Update. Front Immunol 2017; 8: 405. DOI: 10.3389/fimmu.2017.00405</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Alwahaibi N., Alissaei H., Al-Kalbani A., Alabri N., Allawati Z., Albalooshi M. Evaluation of interleukin-2, interleukin-8, and tumor necrosis factor-like weak inducer of apoptosis in hemodialysis and renal transplant patients and healthy controls. Saudi J Kidney Dis Transpl 2016; 27(6): 1123–1128. DOI: 10.4103/1319-2442.194594</mixed-citation><mixed-citation xml:lang="en">Alwahaibi N., Alissaei H., Al-Kalbani A., Alabri N., Allawati Z., Albalooshi M. Evaluation of interleukin-2, interleukin-8, and tumor necrosis factor-like weak inducer of apoptosis in hemodialysis and renal transplant patients and healthy controls. Saudi J Kidney Dis Transpl 2016; 27(6): 1123–1128. DOI: 10.4103/1319-2442.194594</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Stenvinkel P., Ketteler M., Johnson R.J., Lindholm B., Pecoits-Filho R., Riella M. et al. IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia––the good, the bad, and the ugly. Kidney Int 2005; 67(4): 1216– 1233. DOI: 10.1111/j.1523-1755.2005.00200.x</mixed-citation><mixed-citation xml:lang="en">Stenvinkel P., Ketteler M., Johnson R.J., Lindholm B., Pecoits-Filho R., Riella M. et al. IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia––the good, the bad, and the ugly. Kidney Int 2005; 67(4): 1216– 1233. DOI: 10.1111/j.1523-1755.2005.00200.x</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Cale С.M. Cytokines and macrophages: implications for normal and abnormal renal development. Pediatr Nephrol 1999; 13(8): 709–715. DOI: 10.1007/s004670050686</mixed-citation><mixed-citation xml:lang="en">Cale С.M. Cytokines and macrophages: implications for normal and abnormal renal development. Pediatr Nephrol 1999; 13(8): 709–715. DOI: 10.1007/s004670050686</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Sinuani I., Beberashvili I., Averbukh Z., Sandbank J. Role of IL-10 in the progression of kidney disease. World J Transplant 2013; 3(4): 91–98. DOI: 10.5500/wjt.v3.i4.91</mixed-citation><mixed-citation xml:lang="en">Sinuani I., Beberashvili I., Averbukh Z., Sandbank J. Role of IL-10 in the progression of kidney disease. World J Transplant 2013; 3(4): 91–98. DOI: 10.5500/wjt.v3.i4.91</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Кудряшова И.П., Оспельникова Т.П., Ершов Ф.И.Динамика показателей цитокинового профиля при хроническом пиелонефрите. Клиническая нефрология 2012; 4: 39–41.</mixed-citation><mixed-citation xml:lang="en">Kudryashova I.P., Ospel’nikova T.P., Ershov F.I. Dynamics of indicators of the cytokine profile in chronic pyelonephritis. Klinicheskaya nefrologiya 2012; 4: 39–41. (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Маянский А.Н. Лекции по иммунологии. Нижний Новгород: НГМА, 2003; 69.</mixed-citation><mixed-citation xml:lang="en">Mayanskij A.N. Lectures on immunology. Nizhny Novgorod: NGMA, 2003; 69. (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Зорин И.В., Вялкова А.А. Прогнозирование прогрессирования тубуло-интерстициального поражения почек у детей с рефлюкс-нефропатией. Нефрология 2015; 19(3): 65–71.</mixed-citation><mixed-citation xml:lang="en">Zorin I.V., Vyalkova A.A. Prediction of the progression of tubulo-interstitial kidney damage in children with reflux nephropathy. Nefrologiya 2015; 19(3): 65-71. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Зорин И.В., Вялкова А.А., Гунькова Е.В., Куценко Л.В., Плотникова С.В., Чеснокова С.А. и др. Роль цитокинов и факторов роста в формировании и прогрессировании хронической болезни почек у детей. Лечащий врач 2019. https://www.lvrach.ru/2019/09/15437371/.</mixed-citation><mixed-citation xml:lang="en">Zorin I.V., Vyalkova A.A., Gun’kova E.V., Kucenko L.V., Plotnikova S.V., Chesnokova S.A. et al. The role of cytokines and growth factors in the formation and progression of chronic kidney disease in children. Lechashchii vrach 2019. https://www.lvrach.ru/2019/09/15437371/ (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">ПауноваС.С. Рефлюкс-нефропатии. Детская нефрология. Руководство для врачей. Под ред. М.С. Игнатовой. М.: МИА, 2011; 502–511.</mixed-citation><mixed-citation xml:lang="en">Paunova S.S. Reflux nephropathy, In the book: Pediatric nephrology. A guide for doctors. M.S. Ignatova (ed.). Moscow: MIA, 2011; 502–511. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Паунова С.С. Детская нефрология. Учебник. Москва: «МЕДпресс-информ», 2018; 466–467.</mixed-citation><mixed-citation xml:lang="en">Paunova S.S. Children’s nephrology. Textbook. Moscow: MEDpress-inform, 2018; 466–467. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Игнатова М.С. Детская нефрология. Руководство для врачей. М.: ООО «Медицинское информационное агентство», 2011; 696.</mixed-citation><mixed-citation xml:lang="en">Ignatova M.S. Children’s nephrology. A guide for doctors. Moscow: OOO «Medicinskoe informacionnoe agentstvo», 2011; 696. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Дранник Г.Н., Дриянская В.Е., Гайсенюк Ф.З., Руденко М.Ю., Степанова Н.М., Багдасарова И.В. и др. Факторы межклеточной кооперации в иммуногенезе пиелонефрита. Иммунология, аллергология, инфектология 2013; 1: 13–19.</mixed-citation><mixed-citation xml:lang="en">Drannik G.N., Driyanskaya V.E., Gajsenyuk F.Z., Rudenko M.Yu., Stepanova N.M., Bagdasarova I.V. et al. Factors of intercellular cooperation in the immunogenesis of pyelonephritis. Immunologiya, allergologiya, infektologiya 2013; 1: 13–19. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Утц И.А., Захарова Н.Б., Костина М.Л. Современные аспекты межклеточных взаимодействий и их роль в генезе тубулоинтерстициальных нефропатий. Саратовский научно-медицинский журнал 2007; 3(3): 44–49.</mixed-citation><mixed-citation xml:lang="en">Utc I.A., Zaharova N.B., Kostina M.L. Modern aspects of intercellular interactions and their role in the genesis of tubulointerstitial nephropathies. Saratovskii nauchno-medicinskii zhurnal 2007; 3(3): 44–49. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Морозов Д.А., Моррисон В.В., Морозова О.Л., Лакомова Д.Ю. Патогенетические основы и современные возможности ранней диагностики нефросклероза у детей с пузырно-мочеточниковым рефлюксом. Саратовский научно-медицинский журнал 2011; 7(1): 151–157.</mixed-citation><mixed-citation xml:lang="en">Morozov D.A., Morrison V.V., Morozova O.L., Lakomova D.Yu. Pathogenetic principles and modern possibilities of early diagnosis of nephrosclerosis in children with vesicoureteral reflux. Saratovskii nauchno-meditsinskii zhurnal 2011; 7(1): 151–157. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Кореньков Д.Г., Павлова А.Л. Цитокины в определении тяжести активной фазы хронического пиелонефрита. Вестник урологии 2017; 5(3): 4–21. DOI: 10.21886/2308-6424-2017-5-3-14-21</mixed-citation><mixed-citation xml:lang="en">Koren’kov D.G., Pavlova A.L. Cytokines in determining the severity of the active phase of chronic pyelonephritis. Vestnik urologii 2017; 5(3): 14–21. (In Russ.) DOI: 10.21886/2308-6424-2017-5-3-14-21</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Ortega L., Fornoni A. Role of cytokines in the pathogenesis of acute and chronic kidney disease, glomerulonephritis, and end-stage kidney disease. Int J Interferon Cytokine Mediat Res 2010; 2(1): 49–62. DOI: 10.2147/IJICMR.S10111</mixed-citation><mixed-citation xml:lang="en">Ortega L., Fornoni A. Role of cytokines in the pathogenesis of acute and chronic kidney disease, glomerulonephritis, and end-stage kidney disease. Int J Interferon Cytokine Mediat Res 2010; 2(1): 49–62. DOI: 10.2147/IJICMR.S10111</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Simões e Silva A.C., Valério F.C., Vasconcelos M.A., Miranda D.M., OliveiraE.A. Interactions between Cytokines, Congenital Anomalies of Kidney and Urinary Tract and Chronic Kidney Disease. J Immunol Res 2013; 2013: 597920. DOI: 10.1155/2013/597920</mixed-citation><mixed-citation xml:lang="en">Simões e Silva A.C., Valério F.C., Vasconcelos M.A., Miranda D.M., OliveiraE.A. Interactions between Cytokines, Congenital Anomalies of Kidney and Urinary Tract and Chronic Kidney Disease. J Immunol Res 2013; 2013: 597920. DOI: 10.1155/2013/597920</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Меркоданова Ю.А. Цитокиновый профиль мочи при различных этиопатогенетических вариантах хронического пиелонефрита у детей. Саратовский научно-медицинский журнал 2011; 7(4): 901–904.</mixed-citation><mixed-citation xml:lang="en">Merkodanova Yu.A. Urine cytokine profile in various etiopathogenetic variants of chronic pyelonephritis in children. Saratovskij nauchno-meditsinskij zhurnal 2011; 7(4): 901–904. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Хворостов И.Н., Зоркин С. Н., Смирнов Е.И. Значение определения уровней цитокинов при обструктивных уропатиях у детей. Вестник ВолГМУ 2005; 2: 45–49.</mixed-citation><mixed-citation xml:lang="en">Hvorostov I.N., ZorkinS. N., Smirnov E.I. The value of determining the levels of cytokines in obstructive uropathies in children. Vestnik VolGMU 2005; 2: 45–49. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Tullus К., Sjoberg P. Epidemiological Aspects of P-Fimbriated E. coli. Acta Paediatr Scand 1986; 75(2): 205–210. DOI: 10.1111/j.1651-2227.1986.tb10185.x</mixed-citation><mixed-citation xml:lang="en">Tullus К., Sjoberg P. Epidemiological Aspects of P-Fimbriated E. coli. Acta Paediatr Scand 1986; 75(2): 205–210. DOI: 10.1111/j.1651-2227.1986.tb10185.x</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Бычковских В.А. Оценка уровня цитокинов в сыворотки крови больных хроническим пиелонефритом единственной почки в раннем послеоперационном периоде. Курский научно-практический вестник «Человек и его здоровье» 2011; 3: 42–45.</mixed-citation><mixed-citation xml:lang="en">Bychkovskih V.A. Assessment of the level of cytokines in the blood serum of patients with chronic pyelonephritis of a single kidney in the early postoperative period. Kurskii nauchno-prakticheskii vestnik «Chelovek i ego zdorov’e» (Kursk Scientific and Practical Bulletin «Man and His Health») 2011; 3: 42–45. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Захарова Н.Б., ГраждановР.А., Понукалин А.Н., Иноземцева Н.Д., Россоловский А.Н. Диагностическое значение про- и противовоспалительных цитокинов в моче при обострении хронического калькулезного пиелонефрита. Бюллетень медицинских Интернет-конференций 2013; 3(4): 835–838.</mixed-citation><mixed-citation xml:lang="en">Zaharova N.B., GrazhdanovR.A., Ponukalin A.N., Inozemceva N.D., Rossolovskij A.N. Diagnostic value of pro- and anti-inflammatory citokines in urine at an axacerbation of chronic calculous pyelonephritis. Byulleten’ medicinskih Internet-konferencij (Internet Medical Bulletin) 2013; 3(4): 835–838. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Булатова А.В., Макарова Т.П., Маянский А.Н. Диагностическая значимость цитокинового профиля мочи при хроническом пиелонефрите у детей. Казанский медицинский журнал 2010; 91(2): 228–232.</mixed-citation><mixed-citation xml:lang="en">Bulatova A.V., Makarova T.P., Mayanskij A.N. Diagnostic significance of the cytokine profile of urine in children with chronic pyelonephritis. Kazanskii meditsinskii zhurnal 2010; 91(2): 228–232. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Слободян Е.И., Каладзе Н.Н., Говдалюк А.Л. Цитокины мочи – неинвазивные маркеры клиниколабораторной ремиссии у детей с хроническим пиелонефритом. Нефрология 2017; 21(2): 73–82. DOI: 10.24884/1561-6274-2017-21-2-73-82</mixed-citation><mixed-citation xml:lang="en">Slobodyan E.I., Kaladze N.N., Govdalyuk A.L. Urine cytokines are non-invasive markers of clinical laboratory remission in children with chronic pyelonephritis. Nefrologiya 2017; 21(2): 73–82. (In Russ.)] DOI: 10.24884/1561-6274-2017-21-2-73-82</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Renata Y., Jassar H., Katz R., Hochberg A., Nir R.R., Klein-Kremer A. Urinary сoncentration of сytokines in сhildren with acute pyelonephritis. Eur J Pediatr 2013; 72(6): 769–74. DOI: 10.1007/s00431-012-1914-2</mixed-citation><mixed-citation xml:lang="en">Renata Y., Jassar H., Katz R., Hochberg A., Nir R.R., Klein-Kremer A. Urinary сoncentration of сytokines in сhildren with acute pyelonephritis. Eur J Pediatr 2013; 72(6): 769–74. DOI: 10.1007/s00431-012-1914-2</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Lipiec K., AdamczykP., witochowska E., Ziora K., Szczepańska M. L-FABP and IL-6 as markers of chronic kidney damage in children after hemolytic uremic syndrome. Adv Clin Exp Med 2018; 27(7): 955–962. DOI: 10.17219/acem/70567</mixed-citation><mixed-citation xml:lang="en">Lipiec K., AdamczykP., witochowska E., Ziora K., Szczepańska M. L-FABP and IL-6 as markers of chronic kidney damage in children after hemolytic uremic syndrome. Adv Clin Exp Med 2018; 27(7): 955–962. DOI: 10.17219/acem/70567</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Karzakova L.M., Kudryashov S.I., Shestipalova M.V., Leontyeva E.V. Determining of cytokine levels in the urine in clinical practice. Klin Lab Diagn 2019; 64(5): 287–293. DOI: 10.18821/0869-2084-2019-64-5-287-293</mixed-citation><mixed-citation xml:lang="en">Karzakova L.M., Kudryashov S.I., Shestipalova M.V., Leontyeva E.V. Determining of cytokine levels in the urine in clinical practice. Klin Lab Diagn 2019; 64(5): 287–293. DOI: 10.18821/0869-2084-2019-64-5-287-293</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Бегляров Р.О. Про- и противовоспалительные цитокины у детей с различными формами хронического гломерулонефрита. Казанский медицинский журнал 2017; 98(6): 943–948.</mixed-citation><mixed-citation xml:lang="en">Beglyarov R.O. Pro- and anti-inflamattory cytokines in children with various clinical forms of chronic glomerulonephritis. Kazanskii medicinskii zhurnal 2017; 98(6): 943–948. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Zwiech R. Predictive value of conjointly examined IL-1ra, TNF-RI, TNF-RII, and RANTES in patients with primary glomerulonephritis. J Korean Med Sci 2013; 28(2): 261–267. DOI: 10.3346/jkms.2013.28.2.261</mixed-citation><mixed-citation xml:lang="en">Zwiech R. Predictive value of conjointly examined IL-1ra, TNF-RI, TNF-RII, and RANTES in patients with primary glomerulonephritis. J Korean Med Sci 2013; 28(2): 261–267. DOI: 10.3346/jkms.2013.28.2.261</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Жизневская И.И., Хмелевская И.Г. Особенности цитокинового профиля при гломерулопатиях у детей. Курский научно-практический вестник «Человек и его здоровье» 2013; 1: 62–66.</mixed-citation><mixed-citation xml:lang="en">Zhiznevskaya I.I., Hmelevskaya I.G. Peculiarities of the cytokine profile in glomerulopathy in children. Kurskii nauchno-prakticheskii vestnik «Chelovek i ego zdorov’e» (Kursk Scientific and Practical Bulletin «Man and His Health») 2013; 1: 62–66. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Anders H.J. Of inflammasomes and alarmins: IL-1β and IL-1α in Kidney Disease. J Am Soc Nephrol 2016; 27(9): 2564– 2575. DOI: 10.1681/ASN.2016020177</mixed-citation><mixed-citation xml:lang="en">Anders H.J. Of inflammasomes and alarmins: IL-1β and IL-1α in Kidney Disease. J Am Soc Nephrol 2016; 27(9): 2564– 2575. DOI: 10.1681/ASN.2016020177</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Корякова Н.Н. Патогенетические особенности различных клинико-морфологических вариантов хронического гломерулонефрита. Нефрология 2005; 9(1): 58–62.</mixed-citation><mixed-citation xml:lang="en">Koryakova N.N. Pathogenetic features of various clinical and morphological variants of chronic glomerulonephritis. Nefrologiya 2005; 9(1): 58–62. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Kolesnyk M., Driyanska V., Velichko M., DrannikG., Savchenko V. Peculiarities of cytokines and their prognostic value in patients with chronic glomerulonephritis. Ukr J Nephrol Dial 2013; 3(39). DOI: 10.31450/ukrjnd.3(39).2013.04</mixed-citation><mixed-citation xml:lang="en">Kolesnyk M., Driyanska V., Velichko M., DrannikG., Savchenko V. Peculiarities of cytokines and their prognostic value in patients with chronic glomerulonephritis. Ukr J Nephrol Dial 2013; 3(39). DOI: 10.31450/ukrjnd.3(39).2013.04</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Латифова Н.Ф., Эфендиев А.М., Багирова С.А., Джафарова Г.А., Гафаров И.А. Изучение цитокинов и антимикробных пептидов у больных хроническими болезнями почек. Современные проблемы науки и образования 2019; 4: 20. DOI: 10.17513/spno.29031</mixed-citation><mixed-citation xml:lang="en">Latifova N.F., Efendiev A.M., Bagirova S.A., Dzhafarova G.A., Gafarov I.A. Study of cytokines and antimicrobial peptides in patients with chronic kidney diseases. Sovremennye problemy nauki i obrazovaniya 2019; 4: 20. (In Russ.) DOI: 10.17513/spno.29031</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Carrero J.J., Park S.H., Axelsson J., Lindholm B., Stenvinkel P. Cytokines, Atherogenesis, and Hypercatabolism in Chronic Kidney Disease: a dreadful triad. Semin Dial 2009; 22(4): 381–386. DOI: 10.1111/j.1525-139X.2009.00585.x</mixed-citation><mixed-citation xml:lang="en">Carrero J.J., Park S.H., Axelsson J., Lindholm B., Stenvinkel P. Cytokines, Atherogenesis, and Hypercatabolism in Chronic Kidney Disease: a dreadful triad. Semin Dial 2009; 22(4): 381–386. DOI: 10.1111/j.1525-139X.2009.00585.x</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Муркамилов И.Т., Айтбаев К.А., Фомин В.В., Муркамилова Ж.А., Сабиров И.С., Райимжанов З.Р. и др. Провоспалительные цитокины у больных с хронической болезнью почек: в фокусе интерлейкин-6. Архивъ внутренней медицины 2019; 6: 428–433. DOI: 10.20514/2226-6704-2019-9-6-428-433</mixed-citation><mixed-citation xml:lang="en">Murkamilov I.T., Ajtbaev K.A., Fomin V.V., Murkamilova Zh.A., Sabirov I.S., Rajimzhanov Z.R. et al. Pro-inflammatory cytokines in patients with chronic kidney disease: focus on interleukin-6. Arhiv” vnutrennei meditsiny 2019; 6: 428–433. (In Russ.) DOI: 10.20514/2226-6704-2019-9-6-428-433</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Малышев М.Е., Бельских О.А., Сорокина А.А., Зубор О.И. Информативность показателей цитокинового профиля сыворотки крови и слюнной жидкости у больных с хроническими болезнями почек. Курский научно-практический вестник «Человек и его здоровье» 2016; 1: 44–49.</mixed-citation><mixed-citation xml:lang="en">Malyshev M.E., Bel’skih O.A., Sorokina A.A., Zubor O.I. The information content of the cytokine profile of blood serum and salivary fluid in patients with chronic kidney disease. Kurskii nauchno-prakticheskii vestnik «Chelovek i ego zdorov’e» (Kursk Scientific and Practical Bulletin «Man and His Health») 2016; 1: 44–49. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Vianna H.R., Soares C.M., Silveira K.D., Elmiro G.S, Mendes P.M., de Sousa Tavares M. et al. Cytokines in chronic kidney disease: potential link of MCP-1 and dyslipidemia in glomerular diseases. Pediatr Nephrol 2013; 28(3): 463– 469. DOI: 10.1007/s00467-012-2363-x</mixed-citation><mixed-citation xml:lang="en">Vianna H.R., Soares C.M., Silveira K.D., Elmiro G.S, Mendes P.M., de Sousa Tavares M. et al. Cytokines in chronic kidney disease: potential link of MCP-1 and dyslipidemia in glomerular diseases. Pediatr Nephrol 2013; 28(3): 463– 469. DOI: 10.1007/s00467-012-2363-x</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
